PMDA drug package insert
インデラル注射液2mg
PMDA Prescription drug · 太陽ファルマ株式会社 · package insert Aug 25, 2025
Key facts
| Brand names | インデラル注射液2mg |
|---|---|
| Nonproprietary names | プロプラノロール塩酸塩 |
| Companies | 製造販売元／太陽ファルマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ベータ遮断性 不整脈・狭心症 治療剤 |
| Therapeutic category codes | 872123 |
| YJ codes | 2123402A1020 |
| Approval numbers | 14100AZZ04030 |
| Package insert edition | 第2版 |
| Package insert date | Aug 25, 2025 |
| PMDA document key | 431010_2123402A1020_4 |
| PMDA company code | 431010 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: